Iambic Therapeutics, Inc. IAM
14.84 USD -0.54 (-3.54%)
At closeNov 13, 2026, 4:01 AM EST
14.81 -0.03 -0.20%
Pre-market · Nov 13, 4:01 AM ET
14.02 Day range 15.39
9.60 52-week range 25.00
- YTD
- -21.52%
- 1 year
- -21.52%
IAM revenue history
Revenue is income from the company’s ordinary business activities.
9,426,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 9,426,000 | 8,232,000 | 689.45% |
| FY 2024 | 2024-12-31 | 1,194,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-17T06:00:40.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.